Skip to main content
Passa alla visualizzazione normale.

GIAMPAOLO BARONE

Synergistic Anticancer Effects by Enhancing the G‑Quadruplex Binding of Nickel(II) Salphen Complexes through Coupling with S‑Doped Carbon Nanodots

  • Authors: Scialabba C.; Marretta L.; D'Anna L.; Barone G.; Cavallaro G.; Terenzi A.; Mauro N.
  • Publication year: 2024
  • Type: Articolo in rivista
  • Key words: carbon nanodots; G-quadruplex; Nanomedicine; precision cancer therapy; salphen metal complexes; theranostics
  • OA Link: http://hdl.handle.net/10447/665212

Abstract

In recent decades, researchers have focused on developing less toxic and more precise cancer therapies. Carbon nanodots (CDs) are among the most promising technologies due to their high biocompatibility, tunable fluorescence, and ability to facilitate photothermal and photodynamic therapy. This study explores the synthesis and characterization of two CDs conjugated with Salphen metal complexes, namely, CDs-PEG-M1 and CDs-PEG-M2, through Sonogashira coupling. Their interaction with G-quadruplex DNA structures (G4s), motifs largely involved in cancer development, was evaluated using various spectroscopic techniques. The results indicate that CDs-PEG-M1 exhibits greater effectiveness in stabilizing G4 structures compared to the metal complex alone or nonfunctionalized CDs. This enhanced stabilization suggests that CDs-PEG-M1 could reduce the concentration of the metal complex needed for potential antitumor applications, thereby minimizing side effects on nontarget tissues. When tested on breast cancer models (MDA-MB-231 as a triple-negative model and MCF-7 as a HER-2 positive model) and on a healthy cell line (HDFa), the CDs-PEG-M1 conjugate reduced cell viability in a concentration- and time-dependent manner, showing greater potency and selectivity against cancer cells compared to virgin CDs and the free M1 complex. This synergistic anticancer effect, driven by the interaction with G4 structures and reactive oxygen species production, underscores the potential of CDs-PEG-M1 as a targeted nanotheranostic tool.